IDO inhibitor
/ Redx
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 16, 2018
Porcupine inhibitor RXC004 enhances immune response in pre-clinical models of cancer
(AACR 2018)
- "Taken together, data from murine syngeneic mouse models corroborate literature data suggesting that inhibiting the Wnt pathway may promote the immune response against human cancers."
IO Biomarker • PD(L)-1 Biomarker • Melanoma
1 to 1
Of
1
Go to page
1